Origin Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,700	Closed	-$1.42M	–	138
2021 Q2	$1.42M	Hold	7,700	–	–	0.16%	53
2021 Q1	$1.18M	Sell	7,700 -7,000	-48%	-$1.08M	0.12%	67
2020 Q4	$2.3M	Hold	14,700	–	–	0.22%	36
2020 Q3	$1.68M	Sell	14,700 -8,100	-36%	-$874K	0.18%	42
2020 Q2	$2.56M	Sell	22,800 -1,900	-8%	-$202K	0.38%	33
2020 Q1	$2.22M	Sell	24,700 -36,000	-59%	-$3.53M	0.29%	38
2019 Q4	$6.57M	Hold	60,700	–	–	0.55%	51
2019 Q3	$5.95M	Sell	60,700 -9,000	-13%	-$1.01M	0.54%	54
2019 Q2	$9.13M	Sell	69,700 -35,500	-34%	-$4.58M	1.02%	33
2019 Q1	$14.2M	Buy	105,200 +19,200	+22%	+$2.39M	1.19%	38
2018 Q4	$8.37M	Buy	+86,000	New	+$10.2M	0.76%	53
2018 Q1	–	Sell	-56,500	Closed	-$6.76M	–	132
2017 Q4	$6.76M	Hold	56,500	–	–	0.39%	74
2017 Q3	$7.93M	Buy	+56,500	New	+$7.68M	0.49%	64
2015 Q2	–	Sell	-39,292	Closed	-$6.81M	–	116
2015 Q1	$6.81M	Hold	39,292	–	–	0.5%	73
2014 Q4	$7.27M	Sell	39,292 -23,208	-37%	-$4.3M	0.55%	70
2014 Q3	$10.4M	Hold	62,500	–	–	0.67%	61
2014 Q2	$9.77M	Buy	+62,500	New	+$9.87M	0.63%	66

Other funds holding ALXN